Open Accessibility Menu

Antibody Infusion

The Outpatient Antibody Infusion Treatment for COVID-19 is provided at Anderson Regional Medical Center- South:

1102 Constitution Avenue, Meridian, MS 39301

A positive COVID test is required to receive the treatment. Home tests are accepted.

Call 601-703-5161 for more information.

The MSDH COVID Hotline 1-877-978-6453 is available 7 days per week from 7am-7pm to help direct patients to available care.


Monday- Friday 10am-6pm

Saturday 10am-4pm


Call 601-703-5161 when you arrive. Stay in your vehicle until you receive instructions from our staff.


To reduce morbidity and mortality from COVID-19 by treating all persons who meet the treatment criteria established by the U.S. Food and Drug Administration (FDA) outlined in the Emergency Use Authorization (EUA) for the REGEN-COV monoclonal antibody product.


Under these standing orders, eligible healthcare providers are authorized to administer REGEN-COV to adults and adolescents 12 years of age and older who weigh at least 88 pounds. All patients must have a positive COVID-19 test result, including at home test kits, be within 10 days of symptom onset, and meet any of the criteria below:

  1. Older age (for example, age ≥65 years of age)
  2. Obesity or being overweight (for example, BMI >25 kg/m2, or if age 12-17, have BMI ≥85th percentile for their age and gender)
  3. Pregnancy
  4. Chronic kidney disease
  5. Diabetes
  6. Immunosuppressive disease or immunosuppressive treatment
  7. Cardiovascular disease (including congenital heart disease) or hypertension
  8. Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma, interstitial lung disease, cystic fibrosis, and pulmonary hypertension)
  9. Sickle cell disease
  10. Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
  11. Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19))
  12. Other medical conditions or factors (such as race and ethnicity) that may place individuals at an increased risk for progression to more severe disease. Authorization of REGEN-COV under the current EUA is not limited to the medical conditions or factors listed above.

Monoclonal antibodies are not authorized for use in patients:

  1. Who are hospitalized due to COVID-19, OR
  2. Who require oxygen therapy due to COVID-19, OR
  3. Who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity.